Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium yoelii circumsporozoite protein (PyCSP) is the major surface protein of the sporozoite stage of the rodent malaria parasite Plasmodium yoelii. It forms a dense coat on the surface of the sporozoite and plays a critical role in parasite development within the mosquito vector, migration to the salivary glands, and subsequent invasion of host hepatocytes in the mammalian host. PyCSP contains a central repeat region flanked by conserved N-terminal and C-terminal domains, including a cell-adhesive type I thrombospondin repeat (TSR) domain. In vaccine research, PyCSP serves as a vital model antigen for developing pre-erythrocytic malaria vaccines and studying protective humoral and cellular immune responses. Monoclonal antibodies targeting the repeat region of PyCSP, such as NYS1 and 2F6, can neutralize sporozoites and prevent infection, while non-neutralizing antibodies like RAM1 can interfere with this protection.
Neutralization of sporozoites, inhibition of hepatocyte invasion, and induction of protective humoral and cellular immune responses (CD4+ and CD8+ T-cell responses).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium yoelii circumsporozoite protein (PyCSP).